A detailed history of Sit Investment Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Sit Investment Associates Inc holds 82,457 shares of ABBV stock, worth $14.8 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
82,457
Previous 89,377 7.74%
Holding current value
$14.8 Million
Previous $15.3 Million 6.22%
% of portfolio
0.36%
Previous 0.35%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $1.13 Million - $1.38 Million
-6,920 Reduced 7.74%
82,457 $16.3 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $5.24 Million - $6.12 Million
33,847 Added 60.95%
89,377 $15.3 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $3.87 Million - $4.41 Million
24,205 Added 77.27%
55,530 $10.1 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $4.31 Million - $4.85 Million
31,325 New
31,325 $4.85 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $10.7 Million - $13.5 Million
-77,425 Reduced 62.98%
45,509 $6.97 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $4.27 Million - $5.3 Million
-32,366 Reduced 20.84%
122,934 $19.9 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $850,308 - $1.08 Million
-7,915 Reduced 4.85%
155,300 $21 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $2.49 Million - $2.83 Million
-23,440 Reduced 12.56%
163,215 $17.6 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $803,488 - $895,132
7,637 Added 4.27%
186,655 $21 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $1.18 Million - $1.3 Million
11,580 Added 6.92%
179,018 $19.4 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $173,697 - $234,509
2,158 Added 1.31%
167,438 $17.9 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $7.71 Million - $9.05 Million
-89,765 Reduced 90.39%
9,545 $723,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $13.4 Million - $15.7 Million
155,735 Added 1631.59%
165,280 $14.5 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $6.84 Million - $9.16 Million
93,265 Added 1542.85%
99,310 $9.75 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $252,454 - $315,875
-3,500 Reduced 36.67%
6,045 $535,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $3.86 Million - $4.64 Million
-61,220 Reduced 86.51%
9,545 $723,000
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $7.39 Million - $9.45 Million
-112,525 Reduced 61.39%
70,765 $5.15 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $8.27 Million - $9.73 Million
-107,200 Reduced 36.9%
183,290 $14.8 Million
Q4 2018

Jan 14, 2019

SELL
$77.85 - $96.01 $9.19 Million - $11.3 Million
-118,010 Reduced 28.89%
290,490 $26.8 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $78,240 - $86,979
-880 Reduced 0.21%
408,500 $38.6 Million
Q2 2018

Jul 19, 2018

SELL
$89.78 - $106.23 $1.32 Million - $1.56 Million
-14,710 Reduced 3.47%
409,380 $37.9 Million
Q1 2018

Apr 20, 2018

SELL
$92.01 - $123.21 $239,226 - $320,346
-2,600 Reduced 0.61%
424,090 $40.1 Million
Q4 2017

Jan 10, 2018

SELL
$89.56 - $98.21 $424,962 - $466,006
-4,745 Reduced 1.1%
426,690 $41.3 Million
Q3 2017

Oct 18, 2017

BUY
$69.85 - $89.22 $30.1 Million - $38.5 Million
431,435
431,435 $38.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.